These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 29082784)

  • 1. Genderwise clinical response of antipsychotics among schizophrenic patients: a prospective observational study from Lahore, Pakistan.
    Asif U; Saleem Z; Yousaf M; Saeed H; Hashmi FK; Islam M; Hassali MA; Saleem F
    Int J Psychiatry Clin Pract; 2018 Sep; 22(3):177-183. PubMed ID: 29082784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia.
    Adelufosi AO; Abayomi O; Ojo TM
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010501. PubMed ID: 25866243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychoeducation Improves Compliance and Outcome in Schizophrenia Without an Increase of Adverse Side Effects: A 7-Year Follow-up of the Munich PIP-Study.
    Bäuml J; Pitschel-Walz G; Volz A; Lüscher S; Rentrop M; Kissling W; Jahn T
    Schizophr Bull; 2016 Jul; 42 Suppl 1(Suppl 1):S62-70. PubMed ID: 26955982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novelty seeking and medication adherence in patients with schizophrenia.
    Aukst Margetić B; Jakovljević M; Ivanec D; Tošić G; Margetić B
    Psychiatry Res; 2011 Mar; 186(1):141-3. PubMed ID: 20630601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.
    McCann TV; Clark E; Lu S
    J Adv Nurs; 2009 Mar; 65(3):534-43. PubMed ID: 19222651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictors of medication non-adherence among a Moroccan sample of patients with schizophrenia: A cross sectional study].
    El Ammouri A; Kisra H
    Encephale; 2017 Dec; 43(6):522-527. PubMed ID: 27663045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should Antipsychotic Medications for Schizophrenia Be Given for a Lifetime?: A Naturalistic, Long-Term Follow-Up Study.
    Glick ID; Davis JM; Zamora D; Ballon J; Nuthi M
    J Clin Psychopharmacol; 2017 Apr; 37(2):125-130. PubMed ID: 28195931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antipsychotic treatment on tardive dyskinesia: a 6-month evaluation of patients from the European Schizophrenia Outpatient Health Outcomes (SOHO) Study.
    Tenback DE; van Harten PN; Slooff CJ; Belger MA; van Os J;
    J Clin Psychiatry; 2005 Sep; 66(9):1130-3. PubMed ID: 16187770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of symptom severity, insight and increased pharmacologic side effects in acutely hospitalized patients with schizophrenia.
    Zhang J; Rosenheck R; Mohamed S; Zhou Y; Chang Q; Ning Y; He H
    Compr Psychiatry; 2014 Nov; 55(8):1914-9. PubMed ID: 25217308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with medication adherence among patients with schizophrenia in Mekelle, Northern Ethiopia.
    Eticha T; Teklu A; Ali D; Solomon G; Alemayehu A
    PLoS One; 2015; 10(3):e0120560. PubMed ID: 25816353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophrenia medication adherence in a resource-poor setting: randomised controlled trial of supervised treatment in out-patients for schizophrenia (STOPS).
    Farooq S; Nazar Z; Irfan M; Akhter J; Gul E; Irfan U; Naeem F
    Br J Psychiatry; 2011 Dec; 199(6):467-72. PubMed ID: 22130748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that early extrapyramidal symptoms predict later tardive dyskinesia: a prospective analysis of 10,000 patients in the European Schizophrenia Outpatient Health Outcomes (SOHO) study.
    Tenback DE; van Harten PN; Slooff CJ; van Os J
    Am J Psychiatry; 2006 Aug; 163(8):1438-40. PubMed ID: 16877660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia.
    Yang J; Ko YH; Paik JW; Lee MS; Han C; Joe SH; Jung IK; Jung HG; Kim SH
    Schizophr Res; 2012 Feb; 134(2-3):226-31. PubMed ID: 22133906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatrists' judgments about antipsychotic benefit and risk outcomes and formulation in schizophrenia treatment.
    Markowitz MA; Levitan BS; Mohamed AF; Johnson FR; Bridges JF; Alphs L; Citrome L
    Psychiatr Serv; 2014 Sep; 65(9):1133-9. PubMed ID: 24828964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication adherence and subjective weight perception in patients with first-episode psychotic disorder.
    Wong MM; Chen EY; Lui SS; Tso S
    Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):135-41. PubMed ID: 21983497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
    Möller HJ; Riedel M; Jäger M; Wickelmaier F; Maier W; Kühn KU; Buchkremer G; Heuser I; Klosterkötter J; Gastpar M; Braus DF; Schlösser R; Schneider F; Ohmann C; Riesbeck M; Gaebel W
    Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
    Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
    Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
    Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M
    Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.